These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18686225)

  • 21. [Visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes].
    Liu Y; Xiong J; He H; Zhu S; Mo Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):258-61. PubMed ID: 23545832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
    Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
    Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
    Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ
    J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes.
    Szamatowicz J; Kuźmicki M; Telejko B; Zonenberg A; Nikołajuk A; Kretowski A; Górska M
    Ginekol Pol; 2009 Jan; 80(1):14-8. PubMed ID: 19323054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.
    Akturk M; Altinova AE; Mert I; Buyukkagnici U; Sargin A; Arslan M; Danisman N
    J Endocrinol Invest; 2008 Jul; 31(7):610-3. PubMed ID: 18787378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders.
    Kamińska A; Kopczyńska E; Bieliński M; Borkowska A; Junik R
    Endokrynol Pol; 2015; 66(2):108-13. PubMed ID: 25931039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.
    Kang YS; Song HK; Lee MH; Ko GJ; Cha DR
    Diabetes Res Clin Pract; 2010 Aug; 89(2):141-9. PubMed ID: 20409603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.
    El-Mesallamy HO; Kassem DH; El-Demerdash E; Amin AI
    Metabolism; 2011 Jan; 60(1):63-70. PubMed ID: 20605615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration.
    Alexiadou K; Kokkinos A; Liatis S; Perrea D; Katsilambros N; Tentolouris N
    Hormones (Athens); 2012; 11(4):444-50. PubMed ID: 23422767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes.
    Jang HN; Yang YS; Lee SO; Oh TJ; Koo BK; Jung HS
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):382-389. PubMed ID: 31884738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
    Zang H; Jiang F; Cheng X; Xu H; Hu X
    Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
    Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
    Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
    Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of sitagliptin on obese patients with insulin treatment-induced diabetes mellitus.
    Li S; Li H; Wang R; Zhang JP
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3490-3495. PubMed ID: 28829491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.